TY - CHAP
T1 - Cytomegalovirus
AU - Razonable, Raymund R.
AU - Humar, Atul
PY - 2011/5/6
Y1 - 2011/5/6
KW - Alternative strategy and agent(s)
KW - Antiviral prophylaxis - being preferred, valganciclovir
KW - Interpretation of pediatric CMV serology - in donors and recipients <18 months
KW - Prevention of cytomegalovirus (CMV) disease - in solid organ transplant (SOT) recipients
KW - Primary (preferred) strategy and agent
KW - Specific pathogens - cytomegalovirus
KW - Treatment of CMV infection - and disease in SOT recipients
KW - Treatment of acute rejection (if ALG is used)
KW - Type of transplant/modifying circumstance
KW - Type of transplant/modifying circumstance
UR - http://www.scopus.com/inward/record.url?scp=84955363037&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84955363037&partnerID=8YFLogxK
U2 - 10.1002/9781444397949.ch14
DO - 10.1002/9781444397949.ch14
M3 - Chapter
AN - SCOPUS:84955363037
SN - 9780470658277
SP - 34
EP - 41
BT - The AST Handbook of Transplant Infections
PB - Wiley-Blackwell
ER -